Cancer Center Offers New Treatment to Patients with Inoperable Lung Cancers

Houma, LA–01/28/2016

Mary Bird Perkins Cancer Center at TGMC treated its first patient with Stereotactic Body Radiation Therapy (SBRT). This precision treatment can target select small inoperable lung cancers, preserving healthy lung tissue and targeting cancer with a precision not possible with previous treatment approaches.

SBRT is a type of external beam radiation therapy that uses special state-of-the-art equipment to position the patient and precisely deliver radiation to a tumor.  SBRT offers the advantage of a higher radiation dose to tumors with a higher probability of cure. Patients require fewer treatments than conventional radiation therapy and it is also less damaging to healthy lung tissue. This is important for many cancer patients who are not candidates for surgery and may be struggling with other health conditions like emphysema. The total dose of radiation is divided into several smaller doses given over several days. This therapy is also being studied as a promising new treatment for other types of cancer.

“We are proud to offer the latest in leading-edge technology and treatments to our patients and community,” said Melanie Guilbeaux, director of Mary Bird Perkins Cancer Center at TGMC. “This precision therapy gives our Cancer Center team the ability to treat patients with the best possible options and outcomes right here close to home.”


For more information please call